↓ Skip to main content

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

Overview of attention for article published in Neurology, February 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
1 X user
patent
1 patent
facebook
2 Facebook pages
reddit
2 Redditors
f1000
1 research highlight platform

Readers on

mendeley
251 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
Published in
Neurology, February 2006
DOI 10.1212/01.wnl.0000201252.57661.e1
Pubmed ID
Authors

The NINDS NET-PD Investigators

Abstract

Creatine and minocycline were prioritized for testing in Phase II clinical trials based on a systematic evaluation of potentially disease modifying compounds for Parkinson disease (PD).

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 3 1%
United Kingdom 2 <1%
Portugal 1 <1%
Spain 1 <1%
Egypt 1 <1%
Germany 1 <1%
Unknown 242 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 40 16%
Student > Bachelor 35 14%
Student > Ph. D. Student 30 12%
Student > Master 15 6%
Student > Doctoral Student 14 6%
Other 44 18%
Unknown 73 29%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 65 26%
Agricultural and Biological Sciences 28 11%
Neuroscience 28 11%
Nursing and Health Professions 7 3%
Psychology 7 3%
Other 31 12%
Unknown 85 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2025.
All research outputs
#9,599,202
of 34,752,441 outputs
Outputs from Neurology
#13,187
of 26,770 outputs
Outputs of similar age
#69,314
of 256,669 outputs
Outputs of similar age from Neurology
#67
of 139 outputs
Altmetric has tracked 34,752,441 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 26,770 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 139 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.